Introduction
Introduction Statistics Contact Development Disclaimer Help
DTIC ADA150715: Nonspecific Resistance Induced by an Immunopharmaco...
by Defense Technical Information Center
Thumbnail
Download
Web page
Treatment of mice with Bordetella pertussis vaccine
resulted in resistance to mouse adenovirus infection.
Antiviral activity was associated with surface components
of B. pertussis. Acellular fractions with antiviral
activity were obtained by relatively gentle extraction
methods, i.e., 1.0 M NaCl extraction or Waring blender
treatment. B. pertussis lipopolysaccharide extracted by
the Westphal procedure possessed antiviral activity.
Lipoplysaccharide complexed with protein appeared to have
more activity than purified lipopolysaccharide. B.
pertussis vaccine did not induce cross-reacting
antibodies with either neutralizing or protective
activity toward mouse adenovirus. Peritoneal exudate
cells obtained from mice treated with B. pertussis
vaccine inhibited vesicular stomatitis virus
multiplication in L-929 cells. Removal of adherent cells
from the peritoneal exudate cell population increased the
antiviral activity toward vesicular stomatitis virus.
Mouse adenovirus migrates from the peritoneum to the
blood within minutes after intraperitoneal inoculation.
Infection with sublethal doses of mouse adenovirus
resulted in a transient splenomegaly. Mice developed
maximal neutralizing antibody titers after infection with
as little as 10 plaque-forming units. Infection with
lethal does of mouse adenovirus resulted in a fever
response (hypothermia) before death.
Date Published: 2018-01-28 16:22:32
Identifier: DTIC_ADA150715
Item Size: 15870557
Language: english
Media Type: texts
# Topics
DTIC Archive; Winters,A L ; ALABAMA ...
# Collections
dticarchive
additional_collections
# Uploaded by
@chris85
# Similar Items
View similar items
PHAROS
You are viewing proxied material from tilde.pink. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.